ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,11
0,00%
Dow Jones
39 671,04
-0,51%
DAX
18 680,20
-0,25%
Brent Oil
81,275
-0,31%
Bitcoin
69 399,13
0,43%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ACELYRIN Inc (SLRN)

  7. ACELYRIN Inc (SLRN) Actualités

SLRN ACELYRIN Inc

4,52
0,19 (4,39%)
22 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ACELYRIN Inc SLRN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,19 4,39% 4,52 23:59:34
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,63 4,33 4,83 4,52 4,33
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/5/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202414:13EDGAR2Form 8-K - Current report
09/5/202414:01GLOBEACELYRIN, INC. Provides Business Update and Highlights Key..
09/5/202414:00GLOBEACELYRIN, INC. Announces Leadership Transition
29/4/202422:05GLOBEACELYRIN, INC. to Report First Quarter 2024 Financial..
28/3/202421:05GLOBEACELYRIN, INC. Reports Full Year 2023 Financial Results and..
27/3/202421:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
20/3/202412:00GLOBEACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept..
11/3/202413:05EDGAR2Form 8-K - Current report
11/3/202413:02GLOBEACELYRIN, INC. Announces Positive Top-line Results from Its..
11/3/202413:00GLOBEACELYRIN, INC. Announces Long-term 32-Week Data from the..
15/2/202422:05GLOBEACELYRIN, INC. Appoints Agnes Lee as Senior Vice President,..
12/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/1/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
20/12/202322:38EDGAR2Form 8-K - Current report
20/12/202322:30GLOBEACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/12/202314:00PRNUSDiCello Levitt LLP Announces Investor Class Action Lawsuit..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/11/202312:03IHMARKETNEWSTuesday’s Wall Street Highlights: Zscaler, Shein, 3M, Meta..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202322:31EDGAR2Form 8-K - Current report
27/11/202322:30GLOBEACELYRIN, INC. Provides Update on Izokibep Clinical..
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07/11/202322:23EDGAR2Form 8-K - Current report
07/11/202322:05GLOBEACELYRIN, INC. Reports Third Quarter 2023 Financial Results..
06/11/202313:00GLOBEACELYRIN, INC. Appoints Patricia Turney as Chief Technical..
31/10/202321:30GLOBEACELYRIN, INC. to Report Third Quarter 2023 Financial..
06/10/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202313:00GLOBEACELYRIN, INC. Scales for Continued Late-Stage Growth with..
12/9/202315:23IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
12/9/202313:29IHMARKETNEWSTuesday’s Wall Street Highlights: Apple, Acelyrin, WestRock,..
12/9/202302:03DJNStocks to Watch: Oracle, Acelyrin, Humacyte
11/9/202322:05GLOBEACELYRIN, INC. Announces Top-Line Results from..
06/9/202313:00GLOBEACELYRIN, INC. to Present at the Morgan Stanley 21st Annual..
21/8/202322:03EDGAR2Form 8-K - Current report
19/8/202300:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202300:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202300:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:22EDGAR2Form 8-K - Current report
14/8/202322:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05GLOBEACELYRIN, INC. Reports Second Quarter 2023 Financial Results..
07/8/202322:30GLOBEACELYRIN, INC. to Present Second Quarter 2023 Financial..
02/8/202323:05EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
SLRN
ACELYRIN
BIT
P1YER7
NLBNPIT1YER7 20240920 450
BOV
CEED4F
CEEE-D PN
EU
B267
L etat Belge Belgische S...
TSX
HGU
BetaPro Canadian Gold Mi...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés